Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Regenerative medicines are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or natural aging process. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications.
This report elaborates on the current development of the Regenerative Medicines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Merck & Co, Inc
MiMedx Group, Inc
Vericel Corporation
Medtronic
Integra LifeSciences Corporation
Stryker Corporation
Organogenesis Inc
Pfizer Inc
AstraZeneca
By Type:
Tissue Engineering
Immunotherapy
Gene Therapy
Cell Therapy
By Application:
Oncology
Dermatology
Cardiology
Orthopedic & Musculoskeletal Disorders
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Regenerative Medicines Market Overview 2018-2029
-
1.1 China Regenerative Medicines Industry Development Overview
-
1.2 China Regenerative Medicines Industry Development History
-
1.3 China Regenerative Medicines Industry Market Size (2018-2029)
-
1.4 China Regenerative Medicines Market Analysis by Type from Production Side
-
1.4.1 China Regenerative Medicines Production Volume, Production Value and Growth Rate of Tissue Engineering (2018-2029)
-
1.4.2 China Regenerative Medicines Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)
-
1.4.3 China Regenerative Medicines Production Volume, Production Value and Growth Rate of Gene Therapy (2018-2029)
-
1.4.4 China Regenerative Medicines Production Volume, Production Value and Growth Rate of Cell Therapy (2018-2029)
-
1.5 China Regenerative Medicines Market Analysis by Application from Consumption End
-
1.5.1 China Regenerative Medicines Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
1.5.2 China Regenerative Medicines Sales Volume, Sales Value and Growth Rate of Dermatology (2018-2029)
-
1.5.3 China Regenerative Medicines Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)
-
1.5.4 China Regenerative Medicines Sales Volume, Sales Value and Growth Rate of Orthopedic & Musculoskeletal Disorders (2018-2029)
-
1.6 China Regenerative Medicines Market Analysis by Region
-
1.6.1 North China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Regenerative Medicines Market Size and Growth Rate from 2018-2029
Chapter 2 China Regenerative Medicines Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Regenerative Medicines Market Status and Competition at home and abroad in 2023
-
2.2.2 China Regenerative Medicines Market Status and Competition Analysis in 2023
-
2.2.3 China Regenerative Medicines Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Regenerative Medicines Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Regenerative Medicines Industry Development
Chapter 3 Regenerative MedicinesIndustry Chain Analysis
-
3.1 Regenerative Medicines Industry Chain
-
3.2 Regenerative Medicines Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Regenerative Medicines Market
-
3.3 Regenerative Medicines Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Regenerative Medicines Market
Chapter 4 China Regenerative Medicines Market, by Type
-
4.1 China Regenerative Medicines Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Regenerative Medicines Total Production Volume and Growth Rate from Production Side
-
4.5 China Regenerative Medicines Production Volume and Growth Rate, by Type
-
4.5.1 China Regenerative Medicines Production Volume and Growth Rate of Tissue Engineering
-
4.5.2 China Regenerative Medicines Production Volume and Growth Rate of Immunotherapy
-
4.5.3 China Regenerative Medicines Production Volume and Growth Rate of Gene Therapy
-
4.5.4 China Regenerative Medicines Production Volume and Growth Rate of Cell Therapy
Chapter 5 China Regenerative Medicines Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Regenerative Medicines Total Market Size and Growth Rate from Consumption End
-
5.5 China Regenerative Medicines Market Size and Growth Rate, by Application
-
5.5.1 China Regenerative Medicines Market Size and Growth Rate of Oncology
-
5.5.2 China Regenerative Medicines Market Size and Growth Rate of Dermatology
-
5.5.3 China Regenerative Medicines Market Size and Growth Rate of Cardiology
-
5.5.4 China Regenerative Medicines Market Size and Growth Rate of Orthopedic & Musculoskeletal Disorders
Chapter 6 China Regenerative Medicines Market, by Region
-
6.1 China Regenerative Medicines Production Volume and Production Value, by Region
-
6.2 China Regenerative Medicines Sales Volume and Sales Value, by Region
Chapter 7 North China Regenerative Medicines Market Analysis
-
7.1 North China Regenerative Medicines Market, by Type
-
7.2 North China Regenerative Medicines Market, by Application
Chapter 8 Central China Regenerative Medicines Market Analysis
-
8.1 Central China Regenerative Medicines Market, by Type
-
8.2 Central China Regenerative Medicines Market, by Application
Chapter 9 South China Regenerative Medicines Market Analysis
-
9.1 South China Regenerative Medicines Market, by Type
-
9.2 South China Regenerative Medicines Market, by Application
Chapter 10 East China Regenerative Medicines Market Analysis
-
10.1 East China Regenerative Medicines Market, by Type
-
10.2 East China Regenerative Medicines Market, by Application
Chapter 11 Northeast China Regenerative Medicines Market Analysis
-
11.1 Northeast China Regenerative Medicines Market, by Type
-
11.2 Northeast China Regenerative Medicines Market, by Application
Chapter 12 Southwest China Regenerative Medicines Market Analysis
-
12.1 Southwest China Regenerative Medicines Market, by Type
-
12.2 Southwest China Regenerative Medicines Market, by Application
Chapter 13 Northwest China Regenerative Medicines Market Analysis
-
13.1 Northwest China Regenerative Medicines Market, by Type
-
13.2 Northwest China Regenerative Medicines Market, by Application
Chapter 14 Company Profiles
-
14.1 Merck & Co, Inc
-
14.1.1 Merck & Co, Inc Company Profile
-
14.1.2 Merck & Co, Inc Regenerative Medicines Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 MiMedx Group, Inc
-
14.2.1 MiMedx Group, Inc Company Profile
-
14.2.2 MiMedx Group, Inc Regenerative Medicines Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Vericel Corporation
-
14.3.1 Vericel Corporation Company Profile
-
14.3.2 Vericel Corporation Regenerative Medicines Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Medtronic
-
14.4.1 Medtronic Company Profile
-
14.4.2 Medtronic Regenerative Medicines Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Integra LifeSciences Corporation
-
14.5.1 Integra LifeSciences Corporation Company Profile
-
14.5.2 Integra LifeSciences Corporation Regenerative Medicines Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Stryker Corporation
-
14.6.1 Stryker Corporation Company Profile
-
14.6.2 Stryker Corporation Regenerative Medicines Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Organogenesis Inc
-
14.7.1 Organogenesis Inc Company Profile
-
14.7.2 Organogenesis Inc Regenerative Medicines Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Pfizer Inc
-
14.8.1 Pfizer Inc Company Profile
-
14.8.2 Pfizer Inc Regenerative Medicines Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 AstraZeneca
-
14.9.1 AstraZeneca Company Profile
-
14.9.2 AstraZeneca Regenerative Medicines Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Regenerative Medicines Industry Research Conclusions
-
15.2 Regenerative Medicines Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Regenerative Medicines Industry Market Size (2018-2029)
-
Figure China Regenerative Medicines Production Volume, Production Value and Growth Rate of Tissue Engineering (2018-2029)
-
Figure China Regenerative Medicines Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)
-
Figure China Regenerative Medicines Production Volume, Production Value and Growth Rate of Gene Therapy (2018-2029)
-
Figure China Regenerative Medicines Production Volume, Production Value and Growth Rate of Cell Therapy (2018-2029)
-
Figure China Regenerative Medicines Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
Figure China Regenerative Medicines Sales Volume, Sales Value and Growth Rate of Dermatology (2018-2029)
-
Figure China Regenerative Medicines Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)
-
Figure China Regenerative Medicines Sales Volume, Sales Value and Growth Rate of Orthopedic & Musculoskeletal Disorders (2018-2029)
-
Figure North China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
Figure Central China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
Figure South China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
Figure East China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Regenerative Medicines Market Size and Growth Rate from 2018-2029
-
Figure Regenerative Medicines Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Regenerative Medicines Market Share by Type in 2018
-
Figure China Regenerative Medicines Market Share by Type in 2023
-
Figure China Regenerative Medicines Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Regenerative Medicines Production Volume and Growth Rate of Tissue Engineering (2018-2023)
-
Figure China Regenerative Medicines Production Volume and Growth Rate of Immunotherapy (2018-2023)
-
Figure China Regenerative Medicines Production Volume and Growth Rate of Gene Therapy (2018-2023)
-
Figure China Regenerative Medicines Production Volume and Growth Rate of Cell Therapy (2018-2023)
-
Figure China Regenerative Medicines Market Share by Application in 2018
-
Figure China Regenerative Medicines Market Share by Application in 2023
-
Figure China Regenerative Medicines Total Market Size and Growth Rate from Consumption End
-
Figure China Regenerative Medicines Market Size and Growth Rate of Oncology (2018-2023)
-
Figure China Regenerative Medicines Market Size and Growth Rate of Dermatology (2018-2023)
-
Figure China Regenerative Medicines Market Size and Growth Rate of Cardiology (2018-2023)
-
Figure China Regenerative Medicines Market Size and Growth Rate of Orthopedic & Musculoskeletal Disorders (2018-2023)
-
Table China Regenerative Medicines Production Volume by Region (2018-2023)
-
Table China Regenerative Medicines Production Volume Share by Region (2018-2023)
-
Figure China Regenerative Medicines Production Volume Share by Region (2018-2023)
-
Table China Regenerative Medicines Production Value by Region (2018-2023)
-
Table China Regenerative Medicines Production Value Share by Region (2018-2023)
-
Figure China Regenerative Medicines Production Value Share by Region (2018-2023)
-
Table China Regenerative Medicines Sales Volume by Region (2018-2023)
-
Table China Regenerative Medicines Sales Volume Share by Region (2018-2023)
-
Figure China Regenerative Medicines Sales Volume Share by Region (2018-2023)
-
Table China Regenerative Medicines Sales Value by Region (2018-2023)
-
Table China Regenerative Medicines Sales Value Share by Region (2018-2023)
-
Figure China Regenerative Medicines Sales Value Share by Region (2018-2023)
-
Table North China Regenerative Medicines Production Volume by Type (2018-2023)
-
Table North China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Figure North China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Table North China Regenerative Medicines Sales Volume by Application (2018-2023)
-
Table North China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Figure North China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Table Central China Regenerative Medicines Production Volume by Type (2018-2023)
-
Table Central China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Figure Central China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Table Central China Regenerative Medicines Sales Volume by Application (2018-2023)
-
Table Central China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Figure Central China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Table South China Regenerative Medicines Production Volume by Type (2018-2023)
-
Table South China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Figure South China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Table South China Regenerative Medicines Sales Volume by Application (2018-2023)
-
Table South China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Figure South China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Table East China Regenerative Medicines Production Volume by Type (2018-2023)
-
Table East China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Figure East China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Table East China Regenerative Medicines Sales Volume by Application (2018-2023)
-
Table East China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Figure East China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Table Northeast China Regenerative Medicines Production Volume by Type (2018-2023)
-
Table Northeast China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Figure Northeast China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Table Northeast China Regenerative Medicines Sales Volume by Application (2018-2023)
-
Table Northeast China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Table Southwest China Regenerative Medicines Production Volume by Type (2018-2023)
-
Table Southwest China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Figure Southwest China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Table Southwest China Regenerative Medicines Sales Volume by Application (2018-2023)
-
Table Southwest China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Table Northwest China Regenerative Medicines Production Volume by Type (2018-2023)
-
Table Northwest China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Figure Northwest China Regenerative Medicines Production Volume Share by Type (2018-2023)
-
Table Northwest China Regenerative Medicines Sales Volume by Application (2018-2023)
-
Table Northwest China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Regenerative Medicines Sales Volume Share by Application (2018-2023)
-
Table Merck & Co, Inc Company Profile
-
Table Merck & Co, Inc Regenerative Medicines Revenue, Price and Gross (2018-2023)
-
Table MiMedx Group, Inc Company Profile
-
Table MiMedx Group, Inc Regenerative Medicines Revenue, Price and Gross (2018-2023)
-
Table Vericel Corporation Company Profile
-
Table Vericel Corporation Regenerative Medicines Revenue, Price and Gross (2018-2023)
-
Table Medtronic Company Profile
-
Table Medtronic Regenerative Medicines Revenue, Price and Gross (2018-2023)
-
Table Integra LifeSciences Corporation Company Profile
-
Table Integra LifeSciences Corporation Regenerative Medicines Revenue, Price and Gross (2018-2023)
-
Table Stryker Corporation Company Profile
-
Table Stryker Corporation Regenerative Medicines Revenue, Price and Gross (2018-2023)
-
Table Organogenesis Inc Company Profile
-
Table Organogenesis Inc Regenerative Medicines Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Regenerative Medicines Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Regenerative Medicines Revenue, Price and Gross (2018-2023)
-
